Arcturus Therapeutics Holdings Inc (ARCT) — Capital Reinvestment Ratio
Arcturus Therapeutics Holdings Inc (ARCT) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($50.81 Million) in capital expenditures ($354.00K). See ARCT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Arcturus Therapeutics Holdings Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Arcturus Therapeutics Holdings Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Arcturus Therapeutics Holdings Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Arcturus Therapeutics Holdings Inc from 2022 to 2022. For live market cap and broader valuation context, see Arcturus Therapeutics Holdings Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.24x | $31.99 Million | $7.73 Million | — |